DBV Ownership | Who Owns DBV?
DBV Ownership Summary
DBV is owned by 14.63% institutional investors, and 85.37% retail investors. Bioimpact capital is the largest institutional shareholder, holding 13.61% of DBVT shares. Artisan International Small-Mid Investor is the top mutual fund, with 2.30% of its assets in DBV shares.
DBVT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | DBV | 14.63% | - | 85.37% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Bioimpact capital | 5.21M | 13.61% | $108.91M |
| Vivo capital | 2.67M | 6.96% | $55.73M |
| Artisan partners limited partnership | 2.22M | 5.79% | $46.36M |
| Siren | 1.86M | 4.85% | $38.80M |
| Baker bros. advisors lp | 1.46M | 3.82% | $30.53M |
| Perceptive advisors | 964.39K | 2.52% | $20.15M |
| Great point partners | 378.59K | 1.97% | $3.79M |
| Patient square capital lp | 693.53K | 1.81% | $14.49M |
| Adage capital partners gp | 345.93K | 1.80% | $3.46M |
| Octagon capital advisors lp | 574.20K | 1.50% | $12.00M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Bioimpact capital | 5.21M | 8.41% | $108.91M |
| Vivo capital | 2.67M | 4.65% | $55.73M |
| Patient square capital lp | 693.53K | 2.57% | $14.49M |
| Great point partners | 378.59K | 1.56% | $3.79M |
| Yiheng capital management | 170.14K | 1.54% | $3.55M |
| Octagon capital advisors lp | 574.20K | 1.33% | $12.00M |
| Siren | 1.86M | 1.08% | $38.80M |
| Atika capital management | 271.30K | 0.71% | $5.67M |
| Redmile group | 491.34K | 0.68% | $10.26M |
| Perceptive advisors | 964.39K | 0.39% | $20.15M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bioimpact capital | 5.21M | 8.41% | 4.22M |
| Perceptive advisors | 964.39K | 0.39% | 964.39K |
| Duquesne family office | 383.36K | 0.24% | 383.36K |
| Patient square capital lp | 693.53K | 2.57% | 334.48K |
| Ameriprise financial | 231.42K | 0.00% | 231.42K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Braidwell lp | - | - | -7.84M |
| Artisan partners limited partnership | 2.22M | 0.07% | -1.09M |
| Adage capital partners gp | 345.93K | 0.01% | -708.57K |
| Yiheng capital management | 170.14K | 1.54% | -469.63K |
| Schonfeld strategic advisors | - | - | -454.34K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Perceptive advisors | 964.39K | 0.39% | 964.39K | $20.15M |
| Duquesne family office | 383.36K | 0.24% | 383.36K | $8.01M |
| Ameriprise financial | 231.42K | 0.00% | 231.42K | $4.83M |
| Russell investments group | 128.56K | 0.00% | 128.56K | $2.69M |
| Dorsey wright & associates | 102.55K | 0.27% | 102.55K | $2.14M |
Sold Out
| Holder | Change |
|---|---|
| Principal securities | -8.00 |
| Mark sheptoff financial planning | -300.00 |
| Raymond james financial | -916.00 |
| Bank of america corp /de/ | -1.23K |
| Steward partners investment advisory | -1.52K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 48 | -7.69% | 5,604,818 | -65.35% | 14 | 0.21% | 29 | -29.27% | 7 | 75.00% |
| Dec 31, 2025 | 38 | 15.15% | 8,882,967 | 36.26% | 46 | 4.02% | 29 | 93.33% | 3 | -40.00% |
| Sep 30, 2025 | 6 | -78.57% | 46,092 | -99.36% | - | 0.43% | 2 | -89.47% | 1 | -50.00% |
| Jun 30, 2025 | 28 | 64.71% | 7,232,630 | 193.06% | 7 | 130.02% | 19 | 137.50% | 3 | 50.00% |
| Mar 31, 2025 | 17 | -5.56% | 2,467,962 | -9.83% | 2 | 29.69% | 8 | 60.00% | 2 | -83.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Artisan International Small-Mid Investor | 1.36M | 2.30% | -661.34K |
| Artisan Non-U.S. Small-Mid Growth Comp | 1.36M | 2.30% | -661.34K |
| DWS ESG Biotech LC | 59.24K | 0.13% | 59.24K |
| AdvisorShares Dorsey Wright ADR ETF | 46.26K | 0.08% | - |
| Russell Inv Tax-Managed US Mid&Sm Cap S | 45.09K | 0.08% | - |
| Russell Inv US Small Cap Equity Y | 22.71K | 0.04% | - |
| Dorsey Wright Sys Reltv Strength Intl | 18.17K | 0.03% | - |
| Artisan International Small-Mid Tr Fdrs | 16.76K | 0.03% | -49.58K |
| Russell Inv Small Cap Fund F | 15.70K | 0.03% | 8.97K |
| Russell Investment Small Cap Fund F | 15.70K | 0.03% | - |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q4 | - | 5 |
| 2025 Q3 | - | 1 |
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 1 |
DBVT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools